comparemela.com

Latest Breaking News On - Brussels stock exchange bios - Page 1 : comparemela.com

BioSenic raises €500,000 in private placement of new shares

PRESS RELEASE – REGULATED INFORMATION NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED.

France
Canada
Belgium
Paris
France-general
Mont-saint-guibert
Waals-gewest
Japan
South-africa
Australia
Belgian
French

BioSenic S.A. : Information on the total number of voting

Information on the total number of voting rights and shares Mont-Saint-Guibert, Belgium, September 1, 2023, 7.00 am CEST – BIOSENIC (Euronext Brussels and.

France
Belgium
Mont-saint-guibert
Waals-gewest
Paris
France-general
French
Belgian
Seitosei-actifin
Neil-hunter-michelle-boxall
Ghislaine-gasparetto
Neither-the-company

BioSenic puts Phase IIb ALLOB trial on hold

INSIDE INFORMATION Prior efficacy unmatched but excellent safety profile confirmed, timing of ALLOB administration for optimal bone repair to.

Mont-saint-guibert
Waals-gewest
Belgium
France
Paris
France-general
French
Lieven-huysse
Neil-hunter-michelle-boxall
Ghislaine-gasparetto
International-media-enquiries
Ib-communications

BioSenic and Pluristyx sign term sheet for market

INSIDE INFORMATION Potential license agreement to produce and commercialize original and transformed ALLOB cells BioSenic to potentially receive royalty.

Paris
France-general
France
Belgium
Mont-saint-guibert
Waals-gewest
Belgian
French
Annie-florence-loyer
Bert-bouserie
Neil-hunter-michelle-boxall
Seitosei-actifin

BioSenic appoints Yves Sagot as Independent Director

REGULATED INFORMATION Mont-Saint-Guibert, Belgium, January 27, 2023, 7am CET – BioSenic (Euronext Brussels and Paris: BIOS), the clinical stage company.

Mont-saint-guibert
Waals-gewest
Belgium
Paris
France-general
France
Switzerland
Belgian
French
Swiss
Merck-serono
Seitosei-actifin

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.